Secondary malignancies after therapy of indolent non-Hodgkin’s lymphoma by Jonathan W. Friedberg

Get full text

Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab by Rohit Sud, Jonathan W. Friedberg

Get full text

Current directions in the treatment of classical Hodgkin lymphoma by Frank G. Keller, Brad Kahl, Jonathan W. Friedberg

Get full text

Clonally unrelated primary large B‐cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune‐privi... by Giby V. George, Diana G. Aldowitz, Audrey N. Jajosky, Danielle S. Wallace, W. Richard Burack, Jonathan W. Friedberg, Siba El Hussein

Get full text

Overcoming barriers to drug development and enrollment in clinical trials for adolescents and young adults with lymphoma by Keri Toner, Carl E. Allen, Shweta Jain, Brad Kahl, John Leonard, Heather Wasserstrom, Jonathan W. Friedberg, Nita L. Seibel, Kara Kelly

Get full text

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective by Robin M. Reid, Andrea Baran, Jonathan W. Friedberg, Gordon L. Phillips II, Jane L. Liesveld, Michael W. Becker, Lucy Wedow, Paul M. Barr, Laurie A. Milner

Get full text

T083: The Effect of Heart Failure on Management and Outcomes of Older Patients with Hodgkin Lymphoma by Jenica Upshaw, Jason Nelson, Angie Mae Rodday, Anita Kumar, Andreas Klein, Marvin Konstam, John Wong, Iris Jaffe, Bonnie Ky, Jonathan W. Friedberg, Matthew Mauer, David Kent, Susan K. Parsons

Get full text

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma by Ronald Levy, Joshua Brody, David L Porter, Sattva S Neelapu, Koen Van Besien, Michael Werner, Michael R Bishop, Mitchell S Cairo, Sherry Adkins, Stephen M Ansell, Jonathan W Friedberg, Justin P Kline

Get full text

Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001 by Deborah M. Stephens, Hongli Li, Louis S. Constine, Thomas J. Fitzgerald, John P. Leonard, Brad S. Kahl, Joo Y. Song, Michael L. LeBlanc, Sonali M. Smith, Daniel O. Persky, Jonathan W. Friedberg

Get full text

Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort by Lisa M. Rimsza, Hongli Li, Rita M. Braziel, Catherine M. Spier, Daniel O. Persky, Jennifer Dunlap, Michael LeBlanc, Nancy Bartlett, John P. Leonard, Sonali M. Smith, Oliver W. Press, Jonathan W. Friedberg

Get full text

P010: Inferior Outcomes for Young Adults Treated on Advanced Stage Clinical Trials: Report from the HoLISTIC Consortium by Susan K. Parsons, Angie Mae Rodday, Jonathan W. Friedberg, Andrea Gallamini, Eliza Hawkes, David Hodgson, Peter Johnson, Brian Link, Matthew Maurer, Jason Nelson, Kerry J. Savage, Jenica Upshaw, Pier Luigi Zinzani, Andrew M. Evens

Get full text

Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphoma by Manali Kamdar, Hongli Li, Robert W. Chen, Lisa M. Rimsza, Michael L. Leblanc, Timothy S. Fenske, Thomas C. Shea, Paul M. Barr, Tycel J. Phillips, John P. Leonard, Brad S. Kahl, Jonathan W. Friedberg, Sonali M. Smith

Get full text

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis by Pallawi Torka, Levi D. Pederson, Michael V. Knopp, David Poon, Jun Zhang, Brad S. Kahl, Howard R. Higley, Gary Kelloff, Jonathan W. Friedberg, Lawrence H. Schwartz, Wyndham H. Wilson, John P. Leonard, Nancy L. Bartlett, Heiko Schöder, Amy S. Ruppert

Get full text

P004: Advanced stage classical Hodgkin lymphoma (cHL) patients with a positive interim-PET (PET-2) Deauville score (DS) 5 after 2 ABVD cycles: A pooled analysis of individual patie... by Simonetta Viviani, Chiara Pavoni, Sally F. Barrington, Luca Guerra, Heiko Schöder, Peter Johnson, Amy A. Kirkwood, Deborah M. Stephens, Jonathan W. Friedberg, Stephane Chauvie, Michael V. Knopp, Massimo Federico, Gunilla Enblad, Paolo Corradini, Andrea Gallamini, Alessandro Rambaldi, Corrado Tarella

Get full text

Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trialResearch in context by Jonathan W. Friedberg, Michael T. Brady, Myla Strawderman, Brad S. Kahl, Izidore S. Lossos, Jonathon B. Cohen, Patrick M. Reagan, Carla Casulo, Barbara L. Averill, Andrea Baran, Grerk Sutamtewagul, Paul M. Barr, John P. Leonard, John M. Ashton, John G. Strang, Francisco Vega, Derick R. Peterson, Loretta J. Nastoupil

Get full text

P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHE... by Martin Hutchings, Stephen M. Ansell, Joseph M. Connors, Won Seog Kim, Andrea Gallamini, Radhakrishnan Ramchandren, Jonathan W. Friedberg, Ranjana Advani, Andrew M. Evens, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Hyeon-Seok Eom, Jeremy S. Abramson, Cassie Dong, Frank Campana, Keenan Fenton, Markus Puhlmann, David J. Straus, John Radford

Get full text

Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium by Jonathan R. Day, Melissa C. Larson, Urshila Durani, Jean L. Koff, Yucai Wang, Thomas M. Habermann, Izidore S. Lossos, Loretta J. Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B. Cohen, Brad S. Kahl, Jia Ruan, W. Richard Burack, Jonathan W. Friedberg, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Matthew J. Maurer, Carla Casulo

Get full text

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL by Monika Pilichowska, Stefania Pittaluga, Judith A. Ferry, Jessica Hemminger, Hong Chang, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, Jeremy S. Abramson, Athena Kritharis, Francisco J. Hernandez-Ilizaliturri, Izidore S. Lossos, Oliver W. Press, Timothy S. Fenske, Jonathan W. Friedberg, Julie M. Vose, Kristie A. Blum, Deepa Jagadeesh, Bruce Woda, Gaurav K. Gupta, Randy D. Gascoyne, Elaine S. Jaffe, Andrew M. Evens

Get full text

1423 Novel immunotherapy based on commensal-derived peptides to drive an effective CD8 T Cell response against selected tumor-associated antigens (TAAs) by Ana Maia, Stephen Ansell, Philippe Armand, Cécile Gouttefangeas, Jonathan W Friedberg, Alice Talpin, Jerome Kervevan, Lucie Aubergeon, Tifanny Mersceman Blanc, Diana Bachrouche, Chloé Ventujol, Léa Bernard, Amandine Manteau, Jose Villasboas, Antonello Pinto, Francesc Bosch, Ramon García-Sanz, Carlos Grande Garcia, Stephen D Smith, Luca Arcaini, Reid Merryman, Pier Zinzani, Christophe Bonny, Laurent Chene, Joao Gamelas Magalhaes

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia by Justin Kline, Ronald Levy, Joshua Brody, James N. Kochenderfer, Edmund K. Waller, Sundar Jagannath, Michael R. Bishop, David Siegel, David Avigan, Michael Boyiadzis, Jeffrey Miller, Rafat Abonour, Kenneth C. Anderson, Stephen M. Ansell, Lisa Barbarotta, Austin John Barrett, Koen Van Besien, P. Leif Bergsagel, Ivan Borrello, Jill Brufsky, Mitchell Cairo, Ajai Chari, Adam Cohen, Jorge Cortes, Stephen J. Forman, Jonathan W. Friedberg, Ephraim J. Fuchs, Steven D. Gore, Brad S. Kahl, Larry W. Kwak, Marcos de Lima, Mark R. Litzow, Anuj Mahindra, Nikhil C. Munshi, Robert Z. Orlowski, John M. Pagel, David L. Porter, Stephen J. Russell, Karl Schwartz, Margaret A. Shipp, Richard M. Stone, Martin S. Tallman, John M. Timmerman, Frits Van Rhee, Ann Welsh, Michael Werner, Peter H. Wiernik, Madhav V. Dhodapkar

Get full text